-
Mashup Score: 2REMoDL-B: bortezomib + R-CHOP versus R-CHOP in patients with DLBCL - 12 month(s) ago
Andrew Davies, MRCP, PhD, University of Southampton, Southampton, UK, discusses results from a long-term follow-up of the Phase III REMoDL-B…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Pushing the boundaries at the 2023 BSH ASM - 12 month(s) ago
The atmosphere at this year’s Annual Scientific Meeting (ASM) was a particularly energetic mix of excitement and anticipation, alongside some trenchant discussion of the challenges facing the haematology workforce. As nearly 1,600 delegates descended on the International Convention Centre (ICC) in Birmingham under dampish skies, there was a fair bit of side chatter about workloads and staffing…
Source: BSHCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The team from Ron Finlay Communications joined us at #BSH2023 last week and shared their thoughts on the conference: https://t.co/85KvQ0rAgo #ASM #haematology #workforce #conference https://t.co/fTurbtnhrd
-
-
Mashup Score: 0BSH at 60 - 1 year(s) ago
The first meeting of the British Society for Haematology (BSH) took place on 19 November 1960. For 60 years BSH has been dedicated to helping members support people with blood disorders and diseases. Our 60th anniversary is a time for recognising the breadth of roles within the multidisciplinary haematology team and acknowledging the contribution of haematology professionals to the advancement…
Source: BSHCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#Throwback to last week at the #BSH2023 #ASM where @BrJHaem shared copies of some past journal copies from 1957 and some bound copies from 1982 Take a look back at BSH history here: https://t.co/OEHcerNm1e #BSH60 https://t.co/t1FonyNCjR
-
-
Mashup Score: 0
Kim Linton, MBChB, MRCP, PhD, FRCP, University of Manchester and The Christie NHS Foundation Trust, Manchester, UK, shares some insights…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Kim Linton (@TheChristieNHS; @OfficialUoM) shares some insights into the UK NCRI investigator-led REFRACT trial, which will evaluate standard CIT versus novel agents in R/R follicular lymphoma: 🎥 https://t.co/CQqoy98jlk #BSH2023 #LymSM #HemOnc
-
-
Mashup Score: 1Preventing the risk of infection in patients with B-cell malignancies in the era of novel agents - 1 year(s) ago
Robert Weinkove, MA (Cantab), MBBS (Hons), PhD, FRACP, FRCP, Malaghan Institute of Medical Research, Wellington, New Zealand, discusses the importance…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#BSH2023 | @robweinkove of @Malaghan_Inst discusses the importance of addressing the risk of infection in patients with B-cell malignancies in the era of novel agents: 👉https://t.co/01HDFul87C👈 @BritSocHaem #LymSM #ImmunoOnc
-
-
Mashup Score: 1Patient & disease-related factors to consider when selecting patients with MDS for transplant - 1 year(s) ago
Pramila Krishnamurthy, MA, FRCPath, MRCP, PhD, King’s College Hospital NHS Foundation Trust, London, UK, discusses important factors to consider when…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
How do you select patients with MDS for transplant? When is the optimal time to transplant these patients? @drpramilak of @KingsCollegeLon shares some interesting insights & discusses important factors to consider at #BSH2023: 🎥 https://t.co/RMxwz63XAh #MDSsm @BritSocHaem
-
-
Mashup Score: 0
Manoj Raghavan, MBBS, PhD, FRCPath, MRCP, CCST, University of Birmingham, Birmingham, UK, shares some insights into the Phase II REPAIR-MDS…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Find out more about the REPAIR-MDS trial in our exclusive interview with Manoj Raghavan (@HaemOnc; @unibirmingham) filmed at #BSH2023: 🎥 https://t.co/kTebCivhFl @BritSocHaem @REPAIR_MDS #MDSsm #HemOnc
-
-
Mashup Score: 2Factors to consider when selecting between continuous and fixed-duration therapy in CLL - 1 year(s) ago
Talha Munir, MBBS, Leeds Teaching Hospitals NHS Trust, Leeds, UK, shares some insights into factors to consider when selecting between…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Talha Munir (@LeedsHospitals) discusses important factors to consider when selecting between continuous and fixed-duration therapy for patients with CLL: 🎥: https://t.co/C6VtZ1lOWh @BritSocHaem #BSH2023 #CLLsm #LeuSM #HemOnc
-
-
Mashup Score: 1BSH 2023 | VJHemOnc - 1 year(s) ago
The 63rd Annual Scientific Meeting of the British Society for Haematology (BSH) is taking place on 23-25 April 2023 in Birmingham, UK, and will bring hematology professionals together to discuss advances in the field. View all videos The…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
This weekend, we had the pleasure of attending #BSH2023 and interviewing several experts in #HemOnc. Thank you to the organizers & to everyone who spoke with us! Check out our interviews here: 👉 https://t.co/sdjhnfe6xt 👈 @BritSocHaem #LeuSM #MMsm #LymSM #AMLsm #MPNsm https://t.co/uxxK0TNoGu
-
-
Mashup Score: 0BSH at 60 - 1 year(s) ago
The first meeting of the British Society for Haematology (BSH) took place on 19 November 1960. For 60 years BSH has been dedicated to helping members support people with blood disorders and diseases. Our 60th anniversary is a time for recognising the breadth of roles within the multidisciplinary haematology team and acknowledging the contribution of haematology professionals to the advancement…
Source: BSHCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Highlights from the BJHaem session at #BSH2023 A #throwback to a @BrJHaem journal copy from 1957 and some bound copies from 1982 - showing how much the journal has changed in the last 60+ years Take a look back at BSH history here: https://t.co/knH86M6eU0 https://t.co/SzHJQyximM
-
The REMoDL-B trial evaluated whether there was any benefit to adding bortezomib to R-CHOP in patients with various subtypes of DLBCL. Find out more in our interview with Andrew Davies (@unisouthampton): 👉https://t.co/g7ntbMIqp2👈 @BritSocHaem #BSH2023 #LymSM #DLBCL